Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SALONA GLOBAL MEDICAL DEVICE CORPORATION

(SGMD)
  Report
Delayed Bourse de Toronto  -  03:31 2022-12-02 pm EST
0.5900 CAD   -1.67%
12/01Salona Global Medical Announces US$10 Million Debenture Offering
MT
12/01Salona Global Announces Private Placement of up to US$10 Million of Debenture Units
GL
11/29Salona Global Executes Binding Agreement to Acquire Physical Medicine Assets of Biodex Medical Systems
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Salona Global Provides Update on US$7.5M Sales Order;áExpected Earnout Shares for GPO Channel Acquisition

10/05/2022 | 07:31am EST

SAN DIEGO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“SGMD”, “Salona Global” or the ‎‎“Company”) (TSXV:SGMD), ‎an acquisition-oriented medical device company serving the global injury and surgery recovery (known as recovery science) market, today provided an update on the US$7,500,000 sales order (the “Sales Order”) for medical supplies it announced on July 26, 2022. The Sales came through a large customer using the GPO sales channel announced on November 30, 2021.

Through September 30, 2022, approximately 90% of the Sales Order has been delivered. The Company expects to complete delivery of the Sales Order by the end of November 2022 (the ending of the fiscal third quarter). As of August 31, 2020, the Company has received proceeds of $4.2 million. Because the nature of the order, the customer, and its supplier, the Company has determined, due to specific US GAAP accounting rules, that the transaction does not qualify for recognition as revenue, therefore net cash flow will be reflected in the statement of cash flows and the balance sheet based on the previously executed earnout agreements. The total net cash flow earned through the end of September equals approximately $850,000.

“We are always looking to be opportunistic to increase our revenue, profits and cash flow,” said Luke Faulstick, CEO of Salona Global. “While we were not able to book the proceeds as revenue due to a technical accounting rule, we nevertheless expect to increase our cash flow by approximately $1 million this fiscal year because of this opportunity. We continue to see more and more opportunities in every part of our market, from acquisitions to product IP to distribution deals. Our focus for the second quarter has been both to prepare for the integration of the upcoming large acquisition we announced August 15, 2022, as well as delivering this large sales order.”

Total Shares Outstanding Calculation

For the purposes of calculating partially diluted shares outstanding (not including warrants or options), there is a total of 95,842,767 shares.

This is a sum of (1) issued and outstanding common shares of SGMD trading on the TSXV (“Common Shares”), (2) Class “A” non-voting common shares of SGMD, convertible 1-to-1 into Common Shares (“Class “A” Shares”)*, (3) shares issued through satisfaction of earnouts, convertible 1-to-1 into Class “A” Shares, and (4) shares management expects will be issued through the satisfaction of earnouts, convertible 1-to-1 into Class “A” Shares.

The sum is as follows:

  1. 53,707,779 Common Shares;
  2. 1,355,425 Class “A” Shares;
  3. 19,019,000 shares issued to the sellers of South Dakota Partners Inc.‎ who have already earned the right to acquire an equal amount of Class “A” Shares; and
  4. 21,760,563 shares the management expects to issue to (i) the sellers of Mio-Guard, LLC who can earn the right to acquire up to 6,300,000 Class “A” Shares assuming full satisfaction of their earnout provision, (ii) the sellers of Simbex LLC who can earn the right to acquire up to 6,383,954 Class “A” Shares assuming full satisfaction of their earnout provision, (iii) the sellers of Damar Plastics Manufacturing, Inc.‎ who can earn the right to acquire up to 6,576,609 Class “A” Shares assuming full satisfaction of their earnout provision, and (iv) the Agent (as such term is defined in the November 30, 2021 news release) is expected to earn the right to acquire up to 2,500,000 Class “A” shares related to performance of the Sales Order. The Company does not ‎anticipate any additional sales through its LLC subsidiary (“LLC”, as such term is defined in the November 30, 2021 news release). Accordingly, the Company does not expect to issue more than a maximum of 2,500,000 Class “A” Shares to the Agent.

* Class “A” shares have the same attributes as the Common Shares, except that they are not listed on the TSX Venture Exchange, do not carry the right to vote, and are convertible, subject to certain terms and conditions, including a provision prohibiting a holder of Class “A” Shares from converting Class “A” Shares for Common Shares if it would result in such holder holding more than 9.9% of the Common Shares, into Common Shares on a one-for-one basis.

Full financial results from the fiscal second quarter will be filed within the interim ‎‎financial statements for the three and six months ended August 31, 2022, with the ‎United States Securities and ‎Exchange ‎Commission and available at www.sec.gov, ‎‎and with the securities regulatory authorities in certain ‎provinces of ‎Canada and ‎available at ‎www.sedar.com, on or before October 17, 2022.‎

On Monday, October 17, 2022, at 5:00pm (ET), Executive Chairman Les Cross, CEO Luke Faulstick, and CFO Dennis Nelson will hold an earnings call (see details below) to discuss the results, including details on organic growth for the quarter, deal flow and acquisition status and details about revenues, profits, and growth preparation in the current quarter.

Fiscal Second Quarter Earnings Call
Dial In: +1 (800) 245-3047
Conference ID: SALONA

Sign up at http://tinyurl.com/salonaglobalnewsletter for updates on Salona Global delivered directly to your inbox.

For more information please contact:‎

Luke Faulstick ‎
Chief Executive Officer ‎
Tel: 1 (800) 760-6826 ‎
Email: Info@Salonaglobal.com

Additional Information

There can be no assurance that any acquisition (including the large acquisition ‎‎mentioned herein) will ‎be completed or the timing of any ‎acquisitions. Completion of any ‎‎transaction will be subject to, amongst other things, ‎negotiation and execution of ‎‎definitive agreements, applicable ‎director, shareholder ‎and ‎regulatory approvals.‎

Neither the TSXV nor its Regulation Services Provider (as that term is defined in ‎the ‎‎policies of the TSXV) accepts responsibility for the adequacy or accuracy of this ‎release.‎

Unless otherwise specified, all dollar amounts in this press release are expressed ‎in ‎‎Canadian ‎dollars.‎

Certain statements contained in this press release constitute "forward-looking ‎‎information" ‎within the meaning of the Private Securities Litigation Reform Act of ‎‎1995 ‎and applicable ‎Canadian securities laws. These statements can be identified ‎by the use ‎of forward-looking ‎terminology such as “expects” “believes”, “estimates”, "may", "would", ‎‎"could", ‎‎"should", ‎‎"potential", ‎‎‎‎‎"will", "seek", "intend", ‎‎"plan", and "anticipate", and similar ‎expressions as they ‎relate ‎‎‎‎to the Company, ‎including: the Company expecting to complete delivery of the Sales Order by the ‎end of November 30, 2022; the Company filing its financial statements for the three and six months ended August 31, 2022, on October 17, 2022; the Company expecting to increase its cash flow by approximately $1 million this fiscal year because ‎of this opportunity; the Company ‎anticipating it won’t have any additional sales through the LLC and the Agent only having the right to acquire up to a maximum of 2.5 million Class “A” Shares; the sellers of the acquired businesses meeting their full earnout payments; and the Company closing the large acquisition disclosed herein. All ‎statements ‎‎other than ‎statements ‎of ‎historical fact may be ‎forward-‎looking ‎information. Such ‎statements reflect the ‎Company's current views and ‎intentions with respect to future ‎‎events, and current ‎information available to the Company, and ‎are subject to certain ‎risks, ‎‎uncertainties and assumptions, including: the failure of the Agent to perform in the manufacture and sale of the products covered by the Sales Order; the negotiation, execution and closing of a definitive purchase agreement for the large acquisition; and the acquired businesses performing at the level required to achieve the earnout payments. Salona Global cautions ‎that the forward-looking statements contained ‎herein are ‎qualified by important factors ‎that could cause actual results to differ ‎materially from those ‎reflected by such ‎statements. Such factors include but are ‎not limited to the ‎‎general business ‎and ‎‎‎economic ‎conditions in the regions in ‎which ‎Salona Global operates; the ability of ‎Salona Global to ‎execute on key ‎‎priorities, ‎‎including the successful completion of ‎acquisitions, business ‎retention, ‎and ‎‎‎strategic plans and to ‎‎attract, develop ‎and retain ‎key executives; difficulty integrating ‎newly acquired businesses; ‎‎the ability to ‎‎‎implement ‎business ‎strategies and ‎pursue business ‎opportunities; ‎‎disruptions in or ‎‎attacks ‎‎(including ‎cyber-attacks) on ‎Salona Global’s ‎information ‎technology, internet, network ‎‎‎access or other ‎‎voice or ‎data ‎communications systems ‎or services; the evolution of ‎various types of fraud ‎or other ‎‎‎criminal ‎‎behavior to which ‎Salona ‎Global is exposed; the ‎failure of third ‎parties to comply with their obligations to ‎‎Salona Global ‎or its ‎affiliates; the ‎‎‎impact of new and changes to, or application of, current laws and ‎regulations; ‎‎granting of ‎permits and licenses in a highly regulated business; the ‎overall difficult ‎‎‎‎‎‎‎litigation ‎environment, including in the United States; increased competition; ‎changes in ‎foreign ‎currency rates; ‎increased ‎‎‎‎funding ‎costs and market volatility ‎due to market illiquidity ‎and ‎competition for funding; the ‎availability of funds ‎‎‎‎and ‎resources to pursue operations; ‎‎critical ‎accounting estimates and changes to accounting ‎standards, policies, ‎‎‎‎and ‎methods used ‎by Salona Global; the occurrence of ‎natural and unnatural ‎‎catastrophic ‎‎events ‎and claims ‎‎‎‎‎resulting from such events; ‎and risks related to COVID-19 including ‎various ‎recommendations, ‎‎orders ‎and ‎‎‎‎measures ‎of governmental ‎authorities ‎to try to ‎limit the pandemic, including travel ‎‎‎restrictions, border ‎closures, ‎‎‎‎non-essential business ‎‎closures, ‎quarantines, ‎self-‎isolations, ‎shelters-in-place and ‎social distancing, ‎disruptions ‎‎‎‎to ‎markets, economic ‎activity, ‎financing, ‎supply chains and sales channels, and a ‎‎‎deterioration of ‎‎general ‎‎‎economic ‎conditions ‎including ‎a ‎possible national or global ‎recession‎; as ‎well as those ‎risk factors ‎discussed or ‎‎‎referred to in ‎Salona Global’s ‎disclosure ‎‎documents filed with United States Securities and ‎Exchange ‎‎Commission ‎and available at www.sec.gov, and with the securities regulatory authorities in ‎certain ‎‎‎provinces of ‎Canada and available at www.sedar.com. Should any factor affect Salona ‎‎Global in an unexpected ‎‎‎manner, or ‎should ‎assumptions ‎underlying the forward-looking ‎‎information prove incorrect, the actual results or ‎‎‎events ‎may ‎differ ‎‎materially ‎from the ‎results or ‎events predicted. Any such forward-looking information is ‎‎‎expressly ‎qualified ‎‎in its ‎entirety by ‎‎this cautionary statement. Moreover, Salona Global does not assume ‎‎‎‎responsibility for the ‎‎‎accuracy or ‎‎completeness ‎of such forward-looking information. The ‎forward-looking ‎‎‎information ‎included in ‎this press release ‎is ‎made as of the date of this ‎press release and the Company ‎‎undertakes ‎‎‎no obligation to publicly ‎update or ‎revise ‎‎any ‎forward-looking information, other ‎than as required by applicable ‎‎‎law.‎

The securities referred to in this press release have not been, nor will they be, ‎registered ‎under ‎the United States ‎Securities Act of 1933, as amended, and may ‎not be offered or ‎sold within the ‎United States or to, or for the account ‎or benefit ‎of, U.S. persons absent ‎U.S. registration or an ‎applicable exemption from the U.S. ‎registration requirements. ‎‎This press release does not ‎constitute an offer for sale ‎of securities, nor a solicitation for ‎offers to buy any securities. ‎Any ‎public offering ‎of securities in the United States must be ‎made by means of a prospectus ‎‎containing detailed ‎information about the Company ‎and management, as well as ‎financial ‎statements.‎

This press release contains certain pre-released 2023 second quarter financial metrics. The second quarter financial metrics contained in this press release are preliminary and represent the most current information available to the Company's management, as financial closing procedures for the second quarter ended August 31, 2022, are not yet complete. The Company's actual financial statements for such period may result in material changes to the financial metrics summarized in this press release (including by any one financial metric, or all of the financial metrics, being below or above the figures indicated) as a result of the completion of normal quarter end accounting procedures and adjustments, and also what one might expect to be in the final consolidated financial statements based on the financial metrics summarized in this press release. Although the Company believes the expectations reflected in this press release are based upon reasonable assumptions, the Company can give no assurance that actual results will not differ materially from these expectations.



ę GlobeNewswire 2022
All news about SALONA GLOBAL MEDICAL DEVICE CORPORATION
12/01Salona Global Medical Announces US$10 Million Debenture Offering
MT
12/01Salona Global Announces Private Placement of up to US$10 Million of Debenture Units
GL
11/29Salona Global Executes Binding Agreement to Acquire Physical Medicine Assets of Biodex ..
MT
11/29IIROC Trading Resumption - SGMD
AQ
11/29Salona Global Executes Binding Agreement to Acquire the Physical Medicine Assets of Bio..
GL
11/29IIROC Trading Halt - SGMD
AQ
11/29Salona Global Medical Device Corporation entered into a binding agreement to acquire Ph..
CI
10/18Salona Global Announces Second Quarter Results, Posts 153% Year-Over-Year Revenue Growt..
AQ
10/17SALONA GLOBAL MEDICAL DEVICE CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
10/17Salona Global Medical Device Corporation Reports Earnings Results for the Second Quarte..
CI
More news
Financials
Sales 2023 51,1 M 37,9 M 37,9 M
Net income 2023 0,37 M 0,27 M 0,27 M
Net Debt 2023 - - -
P/E ratio 2023 19,7x
Yield 2023 -
Capitalization 32,5 M 24,1 M 24,1 M
Capi. / Sales 2023 0,64x
Capi. / Sales 2024 0,51x
Nbr of Employees 103
Free-Float 76,0%
Chart SALONA GLOBAL MEDICAL DEVICE CORPORATION
Duration : Period :
Salona Global Medical Device Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,59 CAD
Average target price 2,50 CAD
Spread / Average Target 324%
EPS Revisions
Managers and Directors
Luke T. Faulstick Chief Executive Officer & Executive Director
Dennis T. Nelson Chief Financial Officer
Leslie H. Cross Executive Chairman
Kenneth B. Kashkin Independent Non-Executive Director
Kyle Wilks Independent Non-Executive Director
Sector and Competitors